Vision Pharmaceutical’s powders for injections are sterile, pyrogen-free powder substances including our lyophilized material packed in glass container. When sterile water for injection (provided in the packaging) added into this powder. it rapidly form a clear solution that can injected intravenously or intramuscularly.
Parenteral preparations may require the use of excipients such as solvents, substances to enhance solubility, suspending agents, buffering agents, substances to make the preparation isotonic with blood, stabilizers or antimicrobial preservatives. Vision Pharmaceutical ensures that these addition of excipients kept to a minimum. Our R&D department thoroughly investigate and then recommends specific excipients so that they do not adversely affect the stability, bioavailability, safety or efficacy of the active ingredient. It ensured that all the components of the dry powder ampules perfectly compatible with each other.
Vision Pharmaceutical strives to make sure that our manufacturing process meet the standard of cGMP. The following main general guidelines followed at every step of production to meet the requirements.
The quality and grade of raw material, manufacturing machinery, maintenance of the equipment and the method of powder production. maintained at highest standard to ensure the stability of the active substance and of the final product and that the final product sterile and free of pyrogens and particulate matter.
If any antimicrobial agent added, the quantity kept minimum and according to guidelines provided by regulatory authority. Sterilisation performed prior to production and maintained throughout the procedure. For glass container sterilisation autoclave the preferred method because it ensures rapid and complete sterilisation.
Vision Pharmaceutical extra cautious in filling of oxidation sensitive formulas and filling of such powder done in the atmosphere of suitable sterile inert gas, such as nitrogen, whereby the air in the container replaced by this gas.
Suitable and controlled particle size in maintained, dependent upon the intended use of the dry powder formulation.
Vision Pharmaceutical monitors manufacturing process by validation and carrying out appropriate in-process controls. These chalked out in a way to guarantee effectiveness of each stage of production. Monitoring of environmental conditions (especially with respect to particulate and microbial contamination), bacterial endotoxins, pH and clarity of solution. Freedom from particulate matter and integrity of the container-closure system (absence of leakage, etc.) utmost importance in this regard. We ensure that production procedure of powders for injections must include uniformity of mass, moisture content and the ease of reconstitution.
Our quality control department validate every production phase and inspect final product for particulate matter, discoloration. Precipitation of solid matter and other sign of chemical or physical instability. Vision Pharmaceutical guarantees that all our parenteral preparations comply with Test for sterility. Test for bacterial endotoxins, or, where applicable with Test for pyrogens. In single active ingredient formula it ensured that the Sterile Powder for Injection must uniform mass and particle size.